What sector does Summit Therapeutics PLC (SMMT) operate in?
Summit Therapeutics PLC belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Summit Therapeutics PLC (SMMT) current stock price?
As of the latest data, Summit Therapeutics PLC stock price is $15.12, with a previous close of $15.48. Summit Therapeutics PLC lost -$0.36 in the last trading session, representing a -2.33% loss.
What is Summit Therapeutics PLC (SMMT) current market capitalization?
Summit Therapeutics PLC market cap is approximately 11.74 billion.
What is Summit Therapeutics PLC (SMMT) Earnings Per Share (EPS)?
The trailing EPS is -$1.59, and the forward EPS is -$0.88.
What is Summit Therapeutics PLC (SMMT) EBITDA?
Summit Therapeutics PLC EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -250.47 million.
Does Summit Therapeutics PLC (SMMT) pay dividends?
No. Summit Therapeutics PLC does not pay a dividend.
What is Summit Therapeutics PLC (SMMT) beta (volatility) score?
Summit Therapeutics PLC has a beta of -1.314, indicating lower volatility than the overall market.